Cover Image

Evaluation of IAP/SMAC mimetics as latency reversal agents in primary cells and cytokine induction in in vivo models predictive of cytokine release

Saved in:

Bibliographic Details
Main Authors:	B. Howell (Author), W. Shipe (Author), G. Adam (Author), S. Quan (Author), L. Li (Author), C.N.A. Sim (Author), R. Dunham (Author), D. Margolis (Author), B. Henry (Author), D. Hazuda (Author)
Format:	Book
Published:	Elsevier, 2019-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SMAC mimetics are potent latency reversal agents with single agent and combination activity ex vivo
by: R.M. Dunham, et al.
Published: (2017)

SMAC mimetics reverse HIV latency by selective activation of the non-canonical NF-κB pathway
by: G.C. Sampey, et al.
Published: (2017)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019)

The SMAC mimetic AZD5582 reverses HIV latency as a single agent in resting primary CD4+ T cells
by: G. Sampey, et al.
Published: (2019)

The latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaques is potentiated by CD8a cell depletion
by: M. Mavigner, et al.
Published: (2019)

PP 5.4 - 00184 Optimization of Smac Mimetics as HIV-1 Latency Reversing Agents
by: L. Pache, et al.
Published: (2022)

In vitro analysis of different PKC agonists: latency reversal, T-cell activation, cytokine production and isoform selectivity
by: R. Barnard, et al.
Published: (2015)

Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ART
by: A.A. Okoye, et al.
Published: (2019)

The TwistDock workflow for evaluation of bivalent Smac mimetics targeting XIAP
by: Huang Q, et al.
Published: (2019)

Overview of the progress and prospects of SMAC mimetics in cancers: Is it a silver bullet?
by: Almuradova Elvina, et al.
Published: (2022)

SMAC mimetic BV6 enables sensitization of resistant tumor cells but also affects cytokine-induced killer (CIK) cells: a potential challenge for combination therapy
by: Eva eRettinger, et al.
Published: (2014)

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents
by: Shane D. Falcinelli, et al.
Published: (2019)

Targeting apoptotic machinery as approach for anticancer therapy: Smac mimetics as anticancer agents
by: Nevine M.Y. Elsayed, et al.
Published: (2015)

The SMAC Mimetic APG-1387 Sensitizes Immune-Mediated Cell Apoptosis in Hepatocellular Carcinoma
by: Zide Chen, et al.
Published: (2018)

Induction of HIV from latency by a novel molecule
by: N.M. Archin, et al.
Published: (2015)

The contribution of memory CD4+ T cell subset phenotype to latency reversal efficiency
by: D.A. Kulpa, et al.
Published: (2017)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016)

Role of cytokines and nitric oxide in the induction of tuberculostatic macrophage functions
by: Vera L. Petricevich, et al.
Published: (2000)

Dual-targeting peptides@PMO, a mimetic to the pro-apoptotic protein Smac/DIABLO for selective activation of apoptosis in cancer cells
by: Eros Di Giorgio, et al.
Published: (2023)

Memory CD4+ T cell subsets show differential responses to HIV latency-reversing agents
by: D.A. Kulpa, et al.
Published: (2015)

IAPS presidential address
by: Ravindra Ramadwar
Published: (2022)

Effect of Imiquimod on Cytokine Induction in First Trimester Trophoblasts
by: Jerry M. Manlove-Simmons, et al.
Published: (2000)

Differential effects of HIV latency-reversing agents on T cell phenotype and function: implications for HIV cure
by: G. Clutton, et al.
Published: (2015)

Approaches to discover latency-reversing agents
Published: (2015)

Developing and applying ultrasensitive p24 protein immunoassay for HIV latency
by: B.J. Howell, et al.
Published: (2015)

PP 2.9 - 00125 Impact of latency reversal agents on estrogen receptor alpha gene and protein expression
by: C. Ceriani, et al.
Published: (2022)

HIV latency reversal using designed PKC modulators
by: M.D. Marsden, et al.
Published: (2017)

PP 1.33 - 00167 Integrated single-cell multi-omic profiling of HIV latency reversal
by: A. Manickam, et al.
Published: (2022)

Synergistic HIV latency reversal from an in vitro screen of epigenetic and kinase inhibitors
by: D. Irlbeck, et al.
Published: (2017)

The abstracts of IAP meetings will not be covered in JAPID
by: Adileh Shirmohammadi
Published: (2020)

ICAM-1 expression on chondrocytes in rheumatoid arthritis: induction by synovial cytokines
by: M. E. Davies, et al.
Published: (1992)

Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity
by: Gad Monika, et al.
Published: (2010)

CD8 depletion plus signaling of the non-canonical NF-kB pathway reverses latency in SIV-infected, ART-suppressed rhesus macaques
by: M. Mavigner, et al.
Published: (2019)

Leukocyte Lysis and Cytokine Induction by the Human Sexually Transmitted Parasite Trichomonas vaginalis.
by: Frances Mercer, et al.
Published: (2016)

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016)

On the evaluation of scientific papers presented in IAPS conferences
by: Venkatachalam Raveenthiran
Published: (2021)

Evaluation of HIV latency reversal using designed PKC modulators in humanized BLT mice
by: M.D. Marsden, et al.
Published: (2015)

Epigenomic characterisation of a primary cell model of HIV latency
by: E. Browne, et al.
Published: (2019)

Taro Lectin Can Act as a Cytokine-Mimetic Compound, Stimulating Myeloid and T Lymphocyte Lineages and Protecting Progenitors in Murine Bone Marrow
by: Erika Bertozzi de Aquino Mattos, et al.
Published: (2021)

Targeted screens identify new chromatin regulators of HIV latency
by: A.-M. Turner, et al.
Published: (2017)